Physician Resources
Recently Added |view more
News
It Takes a Community for a Winn Scholar to Build a Clinical Trial
“My past experiences with Teach for America in North Philadelphia were a prologue to what I am doing now,” said Austin Williams, MD, MSEd, FACS, a surgical oncologist specializing in breast cancer at Fox Chase Cancer Center and Associate ...
News
Inspiration for Patients and Peers
Meet the Fox Chase physicians and researchers bridging clinical care excellence with breakthroughs in research—bringing new ideas and new hope to peers, patients, and their families.
Course
Young Adult Cancer Symposium:
From Diagnosis Through Survivorship
Date: Wednesday, September 30, 2026 | 5:30 PM - 9:00 PM, Tuesday, October 27, 2026 | 7:00 PM - 9:00 PM
News
This is a randomized, phase 3, multicenter trial designed to determine if induction weekly chemotherapy, when added to standard concurrent chemoradiotherapy and immunotherapy, for locally advanced cervical cancers can improve disease control ...
News
From Fellowship to Faculty: Building a Fox Chase Career
Arielle Weiss, MD, Assistant Professor, Department of Surgery, and Jason Conger, MD, Assistant Professor, Department of Surgery, both in the Division of Gynecologic Oncology, came to Fox Chase Cancer Center shaped by different experiences, ...
News
As he begins his tenure at Fox Chase Cancer Center, Dr. Robert Winn brings a national reputation in cancer leadership, discovery, and equitable access - and a vision for science that reaches farther than the clinic.
News
Doximity Ask AI May Be Smart, but Trusted Answers Still Depend on Physicians Like Dr. Cohn
A longtime Doximity user, Joshua Cohn, MD, FPMRS, Associate Professor, Department of Urology, Fox Chase Cancer Center and Fox Chase – Temple Urologic Institute provider, had relied on the company’s dialer service for years.
News
Fox Chase Researcher Parth Desai Receives Prestigious ASCO Career Development Award
A Fox Chase Cancer Center researcher has received a prestigious national award to advance a novel immunotherapy strategy aimed at one of oncology's most persistent challenges: tumors that resist immune-based treatments.
News
A new study from researchers at Fox Chase Cancer Center and collaborators across multiple institutions has identified a hidden subset of lung cancers that behave more like aggressive neuroendocrine tumors than traditional non-small cell lung cancer (NSCLC).